Cargando…
The challenge in translating basic research discoveries to treatment of Huntington disease
Huntington disease is a rare neurodegenerative disease resulting from insertion and/or expansion of a polyglutamine repeats close to the N-terminal of the huntingtin protein. Although unequivocal genetic tests have been available for about 20 years, current pharmacological treatments do not prevent...
Autores principales: | Mochly-Rosen, Daria, Disatnik, Marie-Helene, Qi, Xin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Landes Bioscience
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4091548/ https://www.ncbi.nlm.nih.gov/pubmed/25054095 http://dx.doi.org/10.4161/rdis.28637 |
Ejemplares similares
-
Impaired GAPDH-induced mitophagy contributes to the pathology of Huntington’s disease
por: Hwang, Sunhee, et al.
Publicado: (2015) -
Potential biomarkers to follow the progression and treatment response of Huntington’s disease
por: Disatnik, Marie-Hélène, et al.
Publicado: (2016) -
The calpain-suppressing effects of olesoxime in Huntington's disease
por: Weber, Jonasz J., et al.
Publicado: (2016) -
Huntington's disease is a multi-system disorder
por: Mielcarek, Michal
Publicado: (2015) -
Aberrant mitochondrial fission in neurons induced by protein kinase Cδ under oxidative stress conditions in vivo
por: Qi, Xin, et al.
Publicado: (2011)